3-Chloro-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 5g

tert-Butyl 1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 95.0%, 1g

1,2,3,6-Tetrahydropyridine hydrochloride, 97.0%, 250mg

2-Chloro-4-formylthiazole, 95.0%, 1g

1-Ethoxy-4-nitroisoquinoline, 98%, 250mg

3-METHYL-1H-PYRAZOLO[3,4-C]PYRIDINE, 97%, 250mg

[(1,1-dioxidotetrahydrothien-3-yl)amino]acetic acid, 95.0%, 1g

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 250mg

Dialysis membrane Spectra/Por® Biotech CE MWCO 100–500, 16 mm, 1 Piece(s)

Thiacetazone>98.0%(HPLC)250mg

2-(2,4-Dichlorophenyl)-N-hydroxyacetimidamide, 95.0%, 100mg

3,3-Dimethyldihydro-2H-pyran-2,6(3H)-dione, 98%, 25g

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 25g